Over the last four quarters, Albemarle has reported a net margin of 16.5% on average. This is a strong margin for a commodity chemicals business, indicating the company has pricing power and cost control that allows it to protect profitability. Albemarle's ability to sustain high margins despite lithium market volatility suggests its business model is well-diversified and its competitive positioning remains intact. The company's disciplined pricing and operational efficiency have enabled it to navigate cyclical downturns in lithium prices. Albemarle's revenue has grown 8.1% year-over-year on average in the last four quarters, demonstrating its capacity to grow even in a challenging market environment. The company's diversified portfolio of specialty chemicals, including lithium, bromine, and catalysts, has provided stability and flexibility to its financial performance. Albemarle's robust margins, revenue growth, and diversified business model make it an attractive investment in the specialty chemicals space. The company's ability to protect profitability through market cycles is a key competitive advantage that should continue to support its long-term growth and shareholder returns. Investors may want to consider adding ALB to their portfolios at the current valuation.